Tue, Jul 29, 2014, 12:15 AM EDT - U.S. Markets open in 9 hrs 15 mins

Recent

% | $
Click the to save as a favorite.

Muscle Pharm Corp. Message Board

  • fkk_kass fkk_kass Feb 3, 2014 8:37 AM Flag

    Q4 profitability is a function of share count

    For the nine months ending Sep 30, weighted shares outstanding were 6,626,125 and net loss was $13,729,627, or $2.07 per share.

    Management provided an estimated loss per share of $1.44 for 2013. Logically, then, Q4 should be break-even if the weighted shares outstanding for the twelve months ending Dec 31 come in around ($13,729,627 / $1.44), or 9,534,463. Below 9,534,463 represents a net profit for Q4, above 9,534,463 represents a net loss for Q4.

    Let's assume the weighted shares outstanding figure comes in at 8,000,000, which is absolutely higher than what the actual number will be. That equates to a loss for the year of (8,000,000 * $1.44) = $11,520,000. This suggests a NET profit (i.e., AFTER non-cash charges) for Q4 of $2M+.

    Which is pretty odd given that management just forecast a net profit of roughly $2.5M for 2014 after 36% revenue growth.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MSLP
10.91-0.09(-0.82%)Jul 28 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.